Valuation: Beijing SL Pharmaceutical Co., Ltd.

Market Cap 5.17B 774M 702M 649M 585M 1.1B 72.99B 1.14B 7.79B 3.09B 38.99B 2.91B 2.84B 124B P/E 2024
-107x
P/E 2025 -21.7x
Enterprise Value 4.03B 603M 547M 506M 456M 860M 56.87B 890M 6.07B 2.41B 30.38B 2.26B 2.22B 96.43B EV / Sales 2024
8.62x
EV / Sales 2025 10.3x
Free-Float
59.02%
Yield 2024
0.27%
Yield 2025 0.14%
1 day-2.14%
1 week-2.33%
Current month+1.00%
1 month-7.54%
3 months-16.72%
6 months-19.65%
Current year-31.75%
1 week 5.01
Extreme 5.01000000
5.25
1 month 4.93
Extreme 4.93
5.53
Current year 4.81
Extreme 4.81
9.4
1 year 4.81
Extreme 4.81
9.4
3 years 4.81
Extreme 4.81
12.86
5 years 4.81
Extreme 4.81
16.09
10 years 4.81
Extreme 4.81
33.03
Manager TitleAgeSince
Chief Executive Officer 62 2006-04-10
Corporate Secretary 60 2006-04-10
Director TitleAgeSince
Chairman 62 2006-04-10
Director/Board Member 60 2009-04-23
Chairman 56 2015-05-27
Date Insider Type Main position Quantity % Market Cap. Importance
11/5/25 Buy

Director

100 0.0000%
10/29/25 Sell

Director

35,100 0.0041%
10/28/25 Sell

Director

340,000 0.0399%
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-2.33%-37.67%-54.81% 774M
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average +0.02%+1.73%+28.08%+69.55% 430B
Weighted average by Cap. +0.54%+3.26%+37.68%+96.47%

Financials

2024 2025
Net sales 660M 98.94M 89.66M 82.93M 74.82M 141M 9.33B 146M 996M 395M 4.98B 371M 363M 15.82B 624M 93.43M 84.66M 78.31M 70.66M 133M 8.81B 138M 941M 373M 4.71B 351M 343M 14.94B
Net income -74.07M -11.1M -10.06M -9.3M -8.39M -15.81M -1.05B -16.37M -112M -44.3M -559M -41.64M -40.76M -1.77B -347M -52.01M -47.13M -43.6M -39.34M -74.13M -4.9B -76.74M -524M -208M -2.62B -195M -191M -8.32B
Net Debt -1.98B -297M -269M -249M -225M -423M -28B -438M -2.99B -1.19B -14.96B -1.11B -1.09B -47.48B -1.14B -171M -155M -143M -129M -244M -16.12B -252M -1.72B -683M -8.61B -642M -628M -27.34B
Projected Income Statement - Annual - Beijing SL Pharmaceutical Co., Ltd.
Logo Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.
Employees
901
Date Price Change Volume
26-11-13 CN¥5.030 -2.14% 11,296,400
26-11-12 CN¥5.140 -0.96% 11,609,500
26-11-11 CN¥5.190 +0.19% 8,537,100
26-11-10 CN¥5.180 +1.57% 10,434,774
26-11-09 CN¥5.100 -0.97% 9,268,500

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing SL Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002038 Stock